KD Logo

Analyzing Ventyx Biosciences Inc (VTYX) After Recent Trading Activity

Ventyx Biosciences Inc’s recently made public that its CEO AND PRESIDENT Mohan Raju unloaded Company’s shares for reported $23299.0 on Apr 02 ’24. In the deal valued at $5.40 per share,4,312 shares were sold. As a result of this transaction, Mohan Raju now holds 1,578,250 shares worth roughly $5.43 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Then, Krueger Christopher W sold 1,651 shares, generating $8,921 in total proceeds. Upon selling the shares at $5.40, the CHIEF BUSINESS OFFICER now owns 284,999 shares.

Before that, Nuss John sold 1,651 shares. Ventyx Biosciences Inc shares valued at $8,921 were divested by the CHIEF SCIENTIFIC OFFICER at a price of $5.40 per share. As a result of the transaction, Nuss John now holds 264,998 shares, worth roughly $0.91 million.

Wells Fargo upgraded its Ventyx Biosciences Inc [VTYX] rating to an Overweight from a an Equal weight in a research note published on March 12, 2024; the price target was increased to $16 from $7. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in mid March from “a Perform” to “an Outperform”. Wells Fargo also remained covering VTYX and has decreased its forecast on November 07, 2023 with a “an Equal weight” recommendation from previously “an Overweight” rating. Stifel revised its rating on November 07, 2023. It rated VTYX as “a Hold” which previously was an “a Buy”.

Price Performance Review of VTYX

On Monday, Ventyx Biosciences Inc [NASDAQ:VTYX] saw its stock jump 5.52% to $3.44. Over the last five days, the stock has lost -30.51%. Ventyx Biosciences Inc shares have risen nearly 39.27% since the year began. Nevertheless, the stocks have fallen -90.12% over the past one year. While a 52-week high of $40.58 was reached on 03/08/24, a 52-week low of $1.87 was recorded on 01/19/24. SMA at 50 days reached $4.55, while 200 days put it at $9.97. A total of 1.67 million shares were traded, compared to the trading of 6.72 million shares in the previous session.

Levels Of Support And Resistance For VTYX Stock

The 24-hour chart illustrates a support level at 3.20, which if violated will result in even more drops to 2.95. On the upside, there is a resistance level at 3.60. A further resistance level may holdings at 3.75. The Relative Strength Index (RSI) on the 14-day chart is 36.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.41%. Stochastics %K at 11.34% indicates the stock is a buying.

Most Popular